Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity.
Leukotriene D4 stimulates prostanoid synthesis in smooth muscle and endothelial cells. Because phospholipases A2 and C have been proposed to regulate prostanoid synthesis, we examined the effect of leukotriene D4 on these activities. Leukotriene D4 treatment resulted in a dose-dependent, stereospecific increase in phospholipase A2 activity with phosphatidylcholine as a substrate. The induction of phospholipase A2 activity occurred just prior to the appearance of prostanoids in the media. Protein and RNA synthesis were required for the increase in phospholipase A2 activity, and the increase in activity resulted from an increase in the apparent Vmax of the phospholipase A2 enzyme. Phospholipase C activity using various substrates was unchanged. We conclude that the increase in prostanoid synthesis observed after leukotriene D4 treatment is a result of an increase in a phospholipase A2 activity.
D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000201:enzymology*; D002417:Cattle; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004727:Endothelium / Q000187:drug effects / Q000201:enzymology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000201:enzymology*; D010740:Phospholipases / Q000378:metabolism*; D010741:Phospholipases A / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D054467:Phospholipases A2; D013189:SRS-A / Q000494:pharmacology*; D010738:Type C Phospholipases / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism
D013189:SRS-A; D003609:Dactinomycin; D003513:Cycloheximide; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2; D010738:Type C Phospholipases